EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Parkinson's Disease, Speech and Neurosurgery

Thomas Ollivier iD, Serge Pinto, Anne-Sophie Rolland, Emeline Cailliau, Gustavo Touzet, S Thobois, A Eusebio, E Hainque, T Rouaud, S Drapier, D Guehl, D Maltete und 16 weitere

Brain and Behavior · 2025-05 · 15 (5)

DOI: 10.1002/brb3.70101 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Brain and Behavior, online erschienen am 29.04.2025. Verfasst von Thomas Ollivier und 27 weiteren Autor:innen. Beteiligte Einrichtung: CHU Lille Department of Medical Pharmacology, University of Lille, Lille Neuroscience and Cognition INSERM, U1172, LiCEND, NS-Park/F-CRIN Network, Li…. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Parkinson Disease, Speech Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French Ministry of Health (533 K€), PREDI-STIM Study: Multicentric study of the predictive factors of the therapeutic response to subthalamic stimulation on th…, France Parkinson charity Association (228 K€): PREDI-STIM study.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Speech impairment is a recognized but unpredictable adverse effect of sub‐thalamic nucleus deep brain stimulation (STN‐DBS) for Parkinson's disease (PD).

Objectives

To evaluate the prevalence of speech impairment 1 year after STN‐DBS in PD patients and to determine the predictive factors for speech outcome following STN‐DBS.

Methods

Data for 417 patients from the French national PREDISTIM study were collected preoperatively. The combined effect of medical treatment and surgery on speech was compared using specific items from dedicated clinical scales (MDS‐UPDRS III.1: primary endpoint) and patient self‐assessment questionnaires (items 34 and 35 of the PDQ39: secondary endpoints). For each variable, three patient groups were generated according to speech outcome at 1 year: worsening, stability, and improvement. In the second step analysis, the three groups were compared for demographic and clinical variables at baseline and STN‐DBS parameters.

Results

There was a significant deterioration in speech of all considered items 1 year after combined STN‐DBS and dopaminergic treatment. Four predictive factors for speech deterioration were detected: (i) the absence of preoperative speech impairment ( p < 0.001); (ii) severity of motor activity of daily living (MDS‐UPDRS II off total score) ( p = 0.037); (iii) high‐intensity stimulation of the left electrode (i.e., above 3.6 V) ( p = 0.046); and (iv) the absence of any change in non‐motor experiences of daily life (MDS‐UPDRS I total score) ( p = 0.048).

Conclusions

Speech outcome should be carefully monitored after STN‐DBS, especially in PD patients without preoperative speech impairment, with motor difficulties in daily‐living activities, and with increased left electrode intensity. Trial Registration ClinicalTrials.gov identifier: NCT02360683.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep Brain StimulationParkinson DiseaseSpeech DisordersAgedFemaleHumansMaleMiddle AgedSeverity of Illness IndexSpeechSubthalamic NucleusTreatment Outcome

Stichwörter der Autor:innen

Parkinson's diseasespeech disorderssub‐thalamic deep brain stimulation

Autor:innen und Institutionen

  • CHU Lille Department of Medical Pharmacology, University of Lille, Lille Neuroscience and Cognition INSERM, U1172, LiCEND, NS-Park/F-CRIN Network, Lille, France.
  • Neurology and Movement Disorders Department, Expert Center for Parkinson's Disease, Lille University Medical Center, Lille, France.
  • CNRS, LPL, Aix-Marseille Université, Aix-en-Provence, France.
  • Biostatistics Department, CHU Lille, Lille, France.
  • Neurosurgical Department, Lille University Medical Center, Lille, France.
  • Faculté de Médecine Lyon Sud Charles Mérieux; CNRS, Institut des Sciences Cognitives, Univ Lyon, Université Claude Bernard Lyon 1, Bron, France.

ORCID-Profile: Thomas Ollivier

Förderung

  • French Ministry of Health (533 K€), PREDI-STIM Study: Multicentric study of the predictive factors of the therapeutic response to subthalamic stimulation on th…
  • France Parkinson charity Association (228 K€): PREDI-STIM study

Zitieren

APA

Ollivier, T., Pinto, S., Rolland, A. S., Cailliau, E., Touzet, G., Thobois, S., Eusebio, A., Hainque, E., Rouaud, T., Drapier, S., Guehl, D., Maltete, D., Anheim, M., Lagha Boukbiza, O., Giordana, C., Tir, M., Hopes, L., Hubsch, C., Jarraya, B., …, & French PREDISTIM study group (2025). Parkinson's Disease, Speech and Neurosurgery. Brain and Behavior, 15(5). https://doi.org/10.1002/brb3.70101

Vancouver

Ollivier T, Pinto S, Rolland AS, Cailliau E, Touzet G, Thobois S, et al. Parkinson's Disease, Speech and Neurosurgery. Brain and Behavior. 2025;15(5). doi:10.1002/brb3.70101

BibTeX
@article{Ollivier2025,
  author = {Ollivier, Thomas and Pinto, Serge and Rolland, Anne-Sophie and Cailliau, Emeline and Touzet, Gustavo and Thobois, S and Eusebio, A and Hainque, E and Rouaud, T and Drapier, S and Guehl, D and Maltete, D and Anheim, M and Lagha Boukbiza, O and Giordana, C and Tir, M and Hopes, L and Hubsch, C and Jarraya, B and Marques, A and Brefel, C and Rascol, O and Corvol, J C and Benatru, I and Defebvre, Luc and Devos, David and Moreau, Caroline and French PREDISTIM study group, French PREDISTIM study group},
  title = {Parkinson's Disease, Speech and Neurosurgery},
  journal = {Brain and Behavior},
  year = {2025},
  volume = {15},
  number = {5},
  doi = {10.1002/brb3.70101}
}
Kostenlos starten →